Polisky, V., Littmann, M., Triastcyn, A. et al. Varicella-zoster virus reactivation and the risk of dementia. Nat Med 31, 4172–4179 (2025). https://doi.org/10.1038/s41591-025-03972-5
Gao, J., Feng, L., Wu, B. et al. The association between varicella zoster virus and dementia: a systematic review and meta-analysis of observational studies. Neurol Sci 45, 27–36 (2024). https://doi.org/10.1007/s10072-023-07038-7
Elhalag RH, Motawea KR, Talat NE, Rouzan SS, Reyad SM, Elsayed SM, Chébl P, Abowafia M, Shah J. Herpes Zoster virus infection and the risk of developing dementia: A systematic review and meta-analysis. Medicine (Baltimore). 2023 Oct 27;102(43):e34503. doi: 10.1097/MD.0000000000034503.
Pomirchy M, Bommer C, Pradella F, Michalik F, Peters R, Geldsetzer P. Herpes Zoster Vaccination and Dementia Occurrence. JAMA. 2025;333(23):2083–2092. doi:10.1001/jama.2025.5013
Eyting, M., Xie, M., Michalik, F. et al. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature 641, 438–446 (2025). https://doi.org/10.1038/s41586-025-08800-x
Tang E, Ray I, Arnold BF, Acharya NR. Recombinant zoster vaccine and the risk of dementia. Vaccine. 2025 Feb 6;46:126673. doi: 10.1016/j.vaccine.2024.126673.
Huang X, Gu BJ. Shingles vaccination and neuroimmune vulnerability. Trends Neurosci. 2025 Sep;48(9):655-662. doi: 10.1016/j.tins.2025.07.003.
Hakami MA, Khan FR, Abdulaziz O, Alshaghdali K, Hazazi A, Aleissi AF, Abalkhail A, Alotaibi BS, Alhazmi AYM, Kukreti N, Binshaya AS. Varicella-zoster virus-related neurological complications: From infection to immunomodulatory therapies. Rev Med Virol. 2024 Jul;34(4):e2554. doi: 10.1002/rmv.2554.
Gao, J., Feng, L., Wu, B. et al. The association between varicella zoster virus and dementia: a systematic review and meta-analysis of observational studies. Neurol Sci 45, 27–36 (2024). https://doi.org/10.1007/s10072-023-07038-7
Elhalag RH, Motawea KR, Talat NE, Rouzan SS, Reyad SM, Elsayed SM, Chébl P, Abowafia M, Shah J. Herpes Zoster virus infection and the risk of developing dementia: A systematic review and meta-analysis. Medicine (Baltimore). 2023 Oct 27;102(43):e34503. doi: 10.1097/MD.0000000000034503.
Pomirchy M, Bommer C, Pradella F, Michalik F, Peters R, Geldsetzer P. Herpes Zoster Vaccination and Dementia Occurrence. JAMA. 2025;333(23):2083–2092. doi:10.1001/jama.2025.5013
Eyting, M., Xie, M., Michalik, F. et al. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature 641, 438–446 (2025). https://doi.org/10.1038/s41586-025-08800-x
Tang E, Ray I, Arnold BF, Acharya NR. Recombinant zoster vaccine and the risk of dementia. Vaccine. 2025 Feb 6;46:126673. doi: 10.1016/j.vaccine.2024.126673.
Huang X, Gu BJ. Shingles vaccination and neuroimmune vulnerability. Trends Neurosci. 2025 Sep;48(9):655-662. doi: 10.1016/j.tins.2025.07.003.
Hakami MA, Khan FR, Abdulaziz O, Alshaghdali K, Hazazi A, Aleissi AF, Abalkhail A, Alotaibi BS, Alhazmi AYM, Kukreti N, Binshaya AS. Varicella-zoster virus-related neurological complications: From infection to immunomodulatory therapies. Rev Med Virol. 2024 Jul;34(4):e2554. doi: 10.1002/rmv.2554.
Mott LR, Caldwell JL. Autonomic imbalance in cardiovascular disease: molecular mechanisms and emerging therapeutics. Am J Physiol Cell Physiol. 2025 Nov 1;329(5):C1511-C1520. doi: 10.1152/ajpcell.00144.2025.
Clyburn C, Sepe JJ, Habecker BA. What gets on the nerves of cardiac patients? Pathophysiological changes in cardiac innervation. J Physiol. 2022 Feb;600(3):451-461. doi: 10.1113/JP281118.
van Weperen VYH, Vaseghi M. The brain-heart axis: effects of cardiovascular disease on the CNS and opportunities for central neuromodulation. Nat Rev Neurosci. 2025 Dec 11. doi: 10.1038/s41583-025-01000-6.
Palantzas A, Anagnostouli M. The Heart-Brain Axis in the Artificial Intelligence Era: Integrating Old and New Insights Towards New Targeting and Innovative Neuro- and Cardio-Therapeutics. Int J Mol Sci. 2025 Aug 24;26(17):8217. doi: 10.3390/ijms26178217.
Normand C, Kaye DM, Povsic TJ, Dickstein K. Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology. Lancet. 2019 Mar 9;393(10175):1045-1055. doi: 10.1016/S0140-6736(18)32216-5.
Montuoro S, Gentile F, Giannoni A. Neuroimmune cross-talk in heart failure. Cardiovasc Res. 2025 May 6;121(4):550-567. doi: 10.1093/cvr/cvae236.
Liu Y, Yang H, Xiong J, Wei Y, Yang C, Zheng Q, Liang F. Brain‑heart axis: Neurostimulation techniques in ischemic heart disease (Review). Int J Mol Med. 2025 Oct;56(4):148. doi: 10.3892/ijmm.2025.5589.
Clyburn C, Sepe JJ, Habecker BA. What gets on the nerves of cardiac patients? Pathophysiological changes in cardiac innervation. J Physiol. 2022 Feb;600(3):451-461. doi: 10.1113/JP281118.
van Weperen VYH, Vaseghi M. The brain-heart axis: effects of cardiovascular disease on the CNS and opportunities for central neuromodulation. Nat Rev Neurosci. 2025 Dec 11. doi: 10.1038/s41583-025-01000-6.
Palantzas A, Anagnostouli M. The Heart-Brain Axis in the Artificial Intelligence Era: Integrating Old and New Insights Towards New Targeting and Innovative Neuro- and Cardio-Therapeutics. Int J Mol Sci. 2025 Aug 24;26(17):8217. doi: 10.3390/ijms26178217.
Normand C, Kaye DM, Povsic TJ, Dickstein K. Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology. Lancet. 2019 Mar 9;393(10175):1045-1055. doi: 10.1016/S0140-6736(18)32216-5.
Montuoro S, Gentile F, Giannoni A. Neuroimmune cross-talk in heart failure. Cardiovasc Res. 2025 May 6;121(4):550-567. doi: 10.1093/cvr/cvae236.
Liu Y, Yang H, Xiong J, Wei Y, Yang C, Zheng Q, Liang F. Brain‑heart axis: Neurostimulation techniques in ischemic heart disease (Review). Int J Mol Med. 2025 Oct;56(4):148. doi: 10.3892/ijmm.2025.5589.